Literature DB >> 2503534

Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function.

I S Fraser1, Z G Lun, J P Zhou, A C Herington, G McCarron, I Caterson, K Tan, R Markham.   

Abstract

Six women with elevated circulating levels of big big PRL (BBPRL) and apparently normal ovarian function were variously studied through a menstrual cycle and menstruation, through pregnancy and suckling, and during stimulation tests with TRH and suppression with bromocriptine. No significant changes in monomeric PRL were demonstrated during the menstrual cycle, but all subjects showed a small and significant rise in BBPRL during the preovulatory phase. High PRL levels were present in day 1 menstrual plasma, but BBPRL was only present in low concentrations. All subjects (n = 5) demonstrated a rise in both PRL and BBPRL during pregnancy, with a consistent tendency for PRL to increase to a proportionately greater extent than BBPRL. One subject exhibited a rise in PRL (by 93%), but not BBPRL, 30 min after suckling. TRH caused a brisk rise in PRL (by 363 +/- 116%) but only a sluggish rise in BBPRL (by 17.5 +/- 7.4%; n = 3). Bromocriptine rapidly suppressed PRL (by 81.8 +/- 34.4%), but only slowly suppressed BBPRL (by 21.0 +/- 8.7% after 6 h; n = 3). Plasma binding studies did not demonstrate any evidence of a circulating specific PRL-binding protein. These data indicate that plasma concentrations of BBPRL may vary under the influence of a number of factors, but are much less sensitive to TRH stimulation, bromocriptine suppression, pregnancy, and suckling than PRL. The occurrence of BBPRL does not seem to be due to a specific circulating binding protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503534     DOI: 10.1210/jcem-69-3-585

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Three cases of macroprolactinaemia.

Authors:  A O Olukoga; T L Dornan; J W Kane
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

2.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

3.  Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.

Authors:  B Cavaco; S Prazeres; M A Santos; L G Sobrinho; V Leite
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

5.  Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.

Authors:  M E Fonseca; R Ochoa; C Morán; A Zárate
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

6.  Macroprolactinemia in a patient with invasive macroprolactinoma: a case report and minireview.

Authors:  Atanaska Elenkova; Zdravka Abadzhieva; Nikolai Genov; Vladimir Vasilev; Georgi Kirilov; Sabina Zacharieva
Journal:  Case Rep Endocrinol       Date:  2013-01-15

7.  Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations.

Authors:  Alfredo Leaños-Miranda; Karla Leticia Ramírez-Valenzuela; Inova Campos-Galicia; Rosario Chang-Verdugo; Lizbeth Zarela Chinolla-Arellano
Journal:  Int J Endocrinol       Date:  2013-09-30       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.